A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir®, in Orthotopic Liver Transplant Recipients

Project: Research project

Project Details

StatusFinished
Effective start/end date1/16/14 → 1/16/16

Funding

  • Covance Inc. (Agmt 01/16/14)
  • Biotest Pharmaceuticals Corporation (Agmt 01/16/14)